UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

__________________

FORM 10-Q

__________________

(Mark One)



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2022~~2023

-OR-


¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission file number 001-40847

__________________

MELI Kaszek Pioneer Corp

(Exact name of Registrant as specified in its Charter)

__________________

Cayman Islands

98-1607040

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

78 SW 7th Street

Individual Office No. 07-156

Miami, Florida 33130

(Former Address) (Zip Code)

(+598) 2927-2770

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

__________________


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A ordinary shares, $0.0001 par value	MEKA	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:


Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	x	Smaller reporting company	x
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

As of ~~November~~May 2110, ~~2022~~2023 there were 29,725,000 Class A ordinary shares, $0.0001 par value per share, and 12,739,286 Class L ordinary shares, $0.0001 par value per share, issued and outstanding.

‎

Table of Contents

MELI KASZEK PIONERR CORP

FORM 10-Q

TABLE OF CONTENTS

Part I - Financial Information		1
Item 1. Condensed Financial Statements (unaudited)		1
Condensed Balance Sheets		1
Condensed Statements of Operations		2
Condensed Statements of Changes in Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit		3
Condensed Statements of Cash Flows		4
Notes to Condensed Financial Statements (unaudited)		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		16
Item 3. Quantitative and Qualitative Disclosures About Market Risk		22
Item 4. Controls and Procedures		22
Part II - Other Information		23
Item 1. Legal Proceedings		23
Item 1A. Risk Factors		23
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		2523
Item 3. Defaults Upon Senior Securities		2624
Item 4. Mine Safety Disclosures		2624
Item 5. Other Information		2624
Item 6. Exhibits		2725
Signatures		2826

Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. Condensed Financial Statements (unaudited)

MELI KASZEK PIONEER CORP

Condensed Balance Sheets

As of September 30, 2022 and December 31, 2021‎


		March 31, ‎2023		December 31, ‎2022
		(unaudited)		(audited)
Assets
Cash	$	407,814	$	669,889
Prepaid expenses		457,936		679,678
Marketable securities held in Trust Account		294,747,472		291,652,889
Total current assets		295,613,222		293,002,456
Total assets	$	295,613,222	$	293,002,456

Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit
Accounts payable and accrued expenses	$	38,419	$	88,297
Class L ordinary shares derivative liability		5,131,712		3,421,120
Total current liabilities		5,170,131		3,509,417
Total liabilities		5,170,131		3,509,417

Commitments and Contingencies
Redeemable Class A ordinary shares subject to possible redemption, 28,750,000 shares at redemption value		294,747,472		291,652,889
Shareholders’ Deficit
Class A ordinary shares, $0.0001 par value; 464,000,000 shares authorized; 975,000 issued and outstanding (excluding 28,750,000 shares subject to possible redemption)		98		98
Additional paid-in capital		—		—
Accumulated deficit		(4,304,479)		(2,159,948)
Total Shareholders’ Deficit		(4,304,381)		(2,159,850)
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit	$	295,613,222	$	293,002,456

		September 30,‎2022		December 31,‎2021
		(unaudited)		(audited)
Assets
Cash	$	815,520	$	1,259,439
Prepaid expenses		861,975		858,375
Marketable securities held in Trust Account		289,220,819		—
Total current assets		290,898,314		2,117,814
Marketable securities held in Trust Account		—		287,505,954
Prepaid expenses - non-current		—		643,781
Total assets	$	290,898,314	$	290,267,549
Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit
Accounts payable and accrued expenses	$	2,180	$	32,419
Class L ordinary shares derivative liability		6,006,206		—
Deferred underwriting discounts and commissions		7,546,875		—
Total current liabilities		13,555,261		32,419
Class L ordinary shares derivative liability		—		84,257,215
Deferred underwriting discounts and commissions		—		10,062,500
Total noncurrent liabilities		—		94,319,715
Total liabilities		13,555,261		94,352,134
Commitments and Contingencies
Redeemable Class A ordinary shares subject to possible redemption, 28,750,000 shares at $10.00 redemption value		289,220,819		287,505,954
Shareholders’ Deficit
Class A ordinary shares, $0.0001 par value; 464,000,000 shares authorized; 975,000 issued and outstanding (excluding 28,750,000 shares subject to possible redemption)		98		98
Additional paid-in capital		—		—
Accumulated deficit		(11,877,864)		(91,590,637)
Total Shareholders’ Deficit		(11,877,766)		(91,590,539)
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit	$	290,898,314	$	290,267,549

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

MELI KASZEK PIONEER CORP

Condensed Statements of Operations

For the nine and three-month periods ended September 30, 2022 and for the period from May 27 (Inception) through September 30, 2021 and three-month period ended September 30, 2021

(Unaudited)

	For the nine-month period ended September 30, 2022		For the three-month period ended September 30, 2022		For the period from May 27, 2021‎(Inception) through September 30, 2021		For the three-month period ended September 30, 2021
	For the three-month period ended March 31, 2023		For the three-month period ended March 31, 2022
General and administrative expenses	$	(1433,~~053,861~~939)	$	(~~314~~422,~~024~~262)	$	~~(10,624)~~	$	—
Loss from operations		(1433,~~053,861~~939)		(~~314~~422,~~024~~262)		~~(10,624)~~		—
Change in fair value of derivative liability		78(1,~~251~~710,~~009~~592)		2636,~~541~~294,~~837~~697		~~(893,835)~~		~~(893,835)~~
Financing expense on derivative liability		—		—		(54,956,475)		(54,956,475)
Investment income on marketable securities held in Trust Account		3,094,583		28,951
Interest on marketable securities held in Trust Account		1,714,865		1,297,684		—		—
Net income	$	950,052	$	35,901,386
Net income (loss)	$	78,912,013	$	27,525,497	$	(55,860,934)	$	(55,850,310)
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted		28,750,000		28,750,000
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted		28,750,000		28,750,000		—		—
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	0.04	$	1.21
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption	$	2.66	$	0.93	$	—	$	—
Weighted average shares outstanding of Class A non-redeemable ordinary shares, basic and diluted		975,000		975,000
Weighted average shares outstanding of Class A non-redeemable ordinary shares, basic and diluted		975,000		975,000		—		—
Basic and diluted net income (loss) per share, Class A non-redeemable ordinary shares	$	(0.07)	$	1.21
Basic and diluted net income per share, Class A non-redeemable ordinary shares	$	2.60	$	0.88	$	—	$	—
Weighted average shares outstanding of Class L ordinary shares, basic and diluted		—		—		12,739,286		12,739,286
Basic and diluted net loss per share, Class L ordinary shares	$	—	$	—	$	(4.38)	$	(4.38)

The accompanying notes are an integral part of these unaudited condensed financial statements.
‎

Table of Contents

MELI KASZEK PIONEER CORP

Condensed Statements of Changes in Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit

For the nine-month period ended September 30, 2022 and for the period from May 27 (Inception) through September 30, 2021

(Unaudited)

	Class A ordinary shares subject to possible redemption			Class A ‎ordinary shares
	Shares		Amount	Shares		Amount	Additional‎Paid-In ‎Capital		Accumulated Deficit		Shareholders’ Deficit
Balance as of December 31, 2021	28,750,000	$	287,505,954	975,000	$	98	$	—	$	(91,590,637)	$	(91,590,539)
Balance as of December 31, 2022	28,750,000	$	291,652,889	975,000	$	98	$	—	$	(2,159,948)	$	(2,159,850)
Accretion of Class A ordinary shares redemption value	—		283,~~951~~094,583	—		—		—		(283,~~951~~094,583)		(283,~~951~~094,583)
Net income	—		—	—		—		—		35950,~~901,386~~052		35950,~~901,386~~052
Balance as of March 31, 2022	28,750,000	$	287,534,905	975,000	$	98	$	—	$	(55,718,202)	$	(55,718,104)
Balance as of March 31, 2023	28,750,000	$	294,747,472	975,000	$	98	$	—	$	(4,304,479)	$	(4,304,381)
Accretion of Class A ordinary shares redemption value	—		388,230	—		—		—		(388,230)		(388,230)
Net income	—		—	—		—		—		15,485,130		15,485,130
Balance as of June 30, 2022	28,750,000	$	287,923,135	975,000	$	98	$	—	$	(40,621,302)	$	(40,621,204)
Accretion of Class A ordinary shares redemption value	—		1,297,684	—		—		—		(1,297,684)		(1,297,684)
Waiver of deferred underwriting discounts and commissions	—		—	—		—		—		2,515,625		2,515,625
Net income	—		—	—		—		—		27,525,497		27,525,497
Balance as of September 30, 2022	28,750,000	$	289,220,819	975,000	$	98	$	—	$	(11,877,864)	$	(11,877,766)

	Class L ‎ordinary shares
	Class A ordinary shares subject to possible redemption				Class A ‎ordinary shares
	Shares		Amount	~~Additional‎Paid-In ‎Capital~~	Shares	~~Accumulated Deficit~~	Amount	~~Shareholders’~~Additional‎Paid-In ~~Deficit~~‎Capital		Accumulated Deficit		Shareholders’ Deficit
Balance as of May 27, 2021 (inception)	—	$	—	$	—	$	—	$	—
Balance as of December 31, 2021	28,750,000	$	287,505,954		975,000	$	98	$	—	$	(91,590,637)	$	(91,590,539)
Issuance of Class L ordinary shares to Sponsor	12,739,286		1,274		23,726		—		25,000
Accretion of Class A ordinary shares redemption value	—		28,951		—		—		—		(28,951)		(28,951)
Net loss	—		—		—		(10,624)		(10,624)
Net income	—		—		—		—		—		35,901,386		35,901,386
Balance as of June 30, 2021	12,739,286	$	1,274	$	23,726	$	(10,624)	$	14,376
Balance as of March 31, 2022	28,750,000	$	287,534,905		975,000	$	98	$	—	$	(55,718,202)	$	(55,718,104)
Reclassification of Class L ordinary shares to derivative liability (Note 5)	(12,739,286)		(1,274)		(23,726)		—		(25,000)
Net loss	—		—		—		(55,850,310)		(55,850,310)
Balance as of September 30, 2021	—	$	—	$	—	$	(55,860,934)	$	(55,860,934)

The accompanying notes are an integral part of these unaudited condensed financial statements.

‎

Table of Contents

MELI KASZEK PIONEER CORP

Condensed Statements of Cash Flows

For the nine-month period ended September 30, 2022 and for the period from May 27 (Inception) through September 30, 2021

(Unaudited)

	For the nine-month period ended September 30, 2022		For the period from May 27, 2021‎(Inception) through September 30, 2021
	For the three-month period ended March 31, 2023		For the three-month period ended March 31, 2022
Cash flows from operating activities:
Net income (loss)	$	78,912,013	$	(55,860,934)
Net income	$	950,052	$	35,901,386
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative liability		~~(78~~1,~~251~~710,~~009)~~592		~~893~~(36,~~835~~294,697)
Financing expense on derivative liabilities		—		54,956,475
Interest on marketable securities held in Trust Account		(1,714,865)		—
Changes in operating assets and liabilities:
Accounts payable and accrued expenses		(3049,~~239~~878)		10(13,~~624~~879)
Prepaid expenses		~~640~~221,~~181~~742		—206,193
Net cash used in operating activities		(443,919)		—
Net cash provided by (used in) operating activities		2,832,508		(200,997)
Cash flows from financing activities:
Cash flows from investing activities:
Proceeds from issuance of promissory payable - related party		—		300,000
Reinvestment of investment income into Trust Account		(3,094,583)		(28,951)
Proceeds from issuance of Class L ordinary shares to Sponsor		—		25,000
Net cash used in investing activities		(3,094,583)		(28,951)
Payments on deferred offering costs included in accrued expenses		—		(319,220)
Net change in cash		(262,075)		(229,948)
Prepaid stock subscription		—		9,750,000
Cash, beginning of the period		669,889		1,259,439
Net cash provided by financing activities		—		9,755,780
Cash, end of the period	$	407,814	$	1,029,491
Net change in cash and restricted cash		(443,919)		9,755,780
Cash and restricted cash, beginning of the period		1,259,439		—
Cash and restricted cash, end of the period	$	815,520	$	9,755,780
Supplemental disclosure of noncash activities:
Deferred offering costs included in accrued offering costs	$	—	$	578,141
Accretion of Class A ordinary shares redemption value	$	3,094,583	$	28,951
Accretion of Class A ordinary shares redemption value	$	1,714,865	$	—
Waiver deferred underwriting discounts and commissions	$	2,515,625	$	—

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

Note 1 — Organization and Business Operations

MELI Kaszek Pioneer Corp (the “Company”) is a Cayman Islands exempted company structured as a blank check company incorporated in the Cayman Islands on May 27, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of ~~September~~March 3031, ~~2022~~2023, the Company had not commenced any operations. All activity for the period ended ~~September~~March 3031, ~~2022~~2023, relates to our search for a target to consummate aan initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of ~~interest~~investment income on cash and cash equivalents from the proceeds derived from the Company’s initial public offering (“IPO”).

The Company’s sponsor is MELI Kaszek Pioneer Sponsor LLC (the “Sponsor”), a Cayman Islands limited liability company.

The registration statement for the Company’s IPO was declared effective on September 28, 2021. On October 1, 2021, the Company consummated the IPO of 28,750,000 Class A ordinary shares (the “Class A ordinary shares”), which includes the exercise in full of the underwriters’ option to purchase an additional 3,750,000 Class A ordinary shares, at $10.00 per share, generating gross proceeds of $287,500,000. Simultaneously with the closing of the IPO, the Company consummated the sale of 975,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per share, generating aggregate gross proceeds to the Company of $9,750,000 which was received prior to the consummation of the IPO.

Transaction costs of the IPO amounted to $16,709,861 consisting of $5,750,000 of underwriting discounts and commissions, $10,062,500 of deferred underwriting discounts and commissions, and $897,361 of other offering costs. ~~During~~As ~~September~~of ~~2022~~December ~~two~~31, of2022 ~~the~~all four underwriters of the IPO waived their entitlement to the deferred underwriting discounts and commissions. AsThe ~~a result~~$10,062,500 ~~the~~waiver ~~underwriting~~was ~~discounts~~recognized ~~and~~in ~~commissions~~accumulated ~~amounted to $7,546,875~~deficit.

Following the closing of the IPO on October 1, 2021, $287,500,000 ($10.00 per share) from the net offering proceeds of the sale of the ~~Shares~~Class A ordinary shares in the IPO and the sale of the Private Placement Shares was placed in a trust account (“Trust Account”) and are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. The Trust Account is intended as a holding place for funds pending the earliest to occur of: (i) the completion of the initial Business Combination; (ii) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (as defined below) (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination within 24 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity; or (iii) absent an initial Business Combination within 24 months from the closing of the IPO, the return of the funds held in the Trust Account to the public shareholders as part of redemption of the public shares.

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their shares of Class A ordinary shares upon the completion of the initial Business Combination either (i) in connection with a shareholder meeting called to approve the initial Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in the Company’s discretion. The public shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination including ~~interest~~investment ~~earned~~income on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to the limitations. The amount in the Trust Account is initially anticipated to be approximately $10.00 per public share.

The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO and subsequently accreted to redemption value, in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity”. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination.

Table of Contents

The Company will have only 24 months from the closing of the IPO on October 1, 2021 (the “Combination Period”) to complete the initial Business Combination. If the Company is unable to complete its initial Business Combination within such 24-month period from the closing of the IPO or during any Extension Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including ~~interest~~investment ~~earned~~income on the funds held in the Trust Account and not previously released to the Company to pay taxes (less up to $100,000 of ~~interest~~investment income to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per public share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. Therefore, there is no assurance that the Sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the Trust Account, the funds available for the Company’s initial Business Combination and redemptions could be reduced to less than $10.00 per public share. In such event, the Company may not be able to complete the initial Business Combination, and a public shareholder would receive such lesser amount per share in connection with any redemption of the public shares. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Risks and Uncertainties

OnUnited ~~January 30,~~States ~~2020,~~and ~~the~~global ~~World~~markets ~~Health~~are ~~Organization~~experiencing ~~("WHO")~~volatility ~~announced~~and adisruption ~~global~~following ~~health~~the ~~emergency~~escalation ~~because~~ of ageopolitical ~~new~~tensions ~~strain~~that ofbegan ~~coronavirus~~in ~~(the~~February ~~"COVID-19~~2022 ~~outbreak").~~from Inthe ~~March~~conflict ~~2020,~~between ~~the~~Russia ~~WHO~~and ~~classified~~Ukraine ~~the~~that ~~COVID-19~~have ~~outbreak~~resulted asin athe ~~pandemic,~~deployment ~~based~~of onmilitary ~~the~~forces ~~rapid~~to ~~increase~~eastern inEurope, ~~exposure~~sanctions ~~globally.~~and ~~The~~other ~~full~~restrictive ~~impact~~actions ofagainst ~~the~~Russia, ~~COVID-19~~Belarus ~~outbreak~~and ~~continues~~related toindividuals ~~evolve~~and entities. ~~Management~~Although ~~continues~~the tolength ~~evaluate~~and ~~the~~ impact of the ~~COVID-19~~ongoing ~~outbreak~~military onconflict ~~the~~in ~~industry~~Ukraine ~~and has concluded that while it~~ is ~~reasonably~~highly ~~possible~~unpredictable, ~~that~~ the ~~virus~~conflict ~~could~~has ~~have~~and acould ~~negative~~continue ~~effect~~to onlead ~~the~~to ~~Company’s~~market ~~financial position~~disruptions, ~~results~~including ofsignificant ~~its~~volatility ~~operations,~~in ~~and~~commodity ~~search~~prices, ~~for~~credit aand ~~target~~capital ~~company~~markets, ~~the~~as ~~specific~~well ~~impact is not readily determinable~~ as ofsupply ~~the~~chain ~~date of these financial statements~~disruptions. ~~The~~Additionally, ~~financial~~Russian ~~statements~~military doactions ~~not~~and ~~include~~the ~~any~~resulting ~~adjustments~~sanctions ~~that~~could ~~might~~adversely ~~result~~affect ~~from~~ the ~~outcome~~global ofeconomy ~~this~~and ~~uncertainty~~financial ormarkets ~~its~~and ~~inability~~lead to ~~continue~~instability asand alack ~~going~~of ~~concern~~liquidity in capital markets.

Table of Contents

United States and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions that began in February 2022 from the conflict between Russia and Ukraine that have resulted in the deployment of military forces to eastern Europe, sanctions and other restrictive actions against Russia, Belarus and related individuals and entities. Although the length and impact of the ongoing military conflict in Ukraine is highly unpredictable, the conflict has and could continue to lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain disruptions. Additionally, Russian military actions and the resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

Any of the abovementioned factors, could adversely affect the search for any target business with which the Company ultimately consummate the initial Business Combination. The extent and duration of conflict, resulting sanctions and any related market disruptions are impossible to predict, but could be substantial, particularly if current or new sanctions continue for an extended period of time or if geopolitical tensions result in expanded military operations on a global scale. Any such disruptions may affect Company’s ability to raise equity or debt financing in connection with any particular Business Combination.

Liquidity and Capital Resources

As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company had $~~815~~407,~~520~~814 and $1669,~~259,439~~889 in cash held outside of the Trust Account.

As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company had working capital of $~~277~~290,~~343~~443,~~053~~091 and $2289,~~085~~493,~~395~~039, respectively. As of ~~September 30~~March 31, ~~2022~~2023, the working capital calculation includes the investments held in the Trust Account as part of current assets and the Class L ordinary shares derivative liability (see Note 6) ~~and the deferred underwriting discounts and commissions (see Note 7)~~ as part of the current liabilities. The Company classified the investments held in the Trust ~~Accounts~~Account as a current asset as the Company has less than 12 months from the balance sheet date to consummate aan initial Business Combination, at which point, if the Company did not find a ~~Business Combination partner~~target, the Company would cease to exist, and the funds would be liquidated from the Trust Account. The Company classified the Class L ordinary shares derivative liability ~~and the deferred underwriting discounts and commissions~~ as current ~~liabilities~~liability as the Company has less than 12 months from the balance sheet date to consummate aan initial Business Combination, at which point, if the Company did not find a ~~Business Combination partner~~target, the Company would cease to exist, and the Class L ordinary shares derivative liability would not be converted~~, and the deferred underwriting discounts and commissions would not be paid as the fees owed are contingent upon a successful Business Combination~~.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, there were no amounts outstanding under any Working Capital Loans.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, on ~~November~~May 145, ~~2022~~2023, the Sponsor provided a firm commitment to the Company of up to $800,000 to be drawn, as needed, over the course of 13 months from the date of the commitment (see Note 5).

Based on the foregoing, management believes that the Company will have sufficient working capital and funding to meet its needs through the earlier of (i) the consummation of a Business Combination or ~~one~~(ii) ~~year~~the ~~from~~liquidation ~~this~~date ~~filing~~of October 1, 2023. Over this time period, the Company will be using the funds held outside of the Trust Account ~~for~~to ~~paying~~pay existing accounts payable, ~~identifying~~identify and ~~evaluating~~evaluate prospective initial Business Combination candidates, ~~performing~~perform due diligence on prospective target businesses, ~~paying~~pay for travel expenditures, ~~selecting~~select the target business to merge with or acquire, and ~~structuring~~structure, ~~negotiating~~negotiate and ~~consummating~~consummate the Business Combination.

Note 2 — Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the periods presented.

The results for the period ended ~~September~~March 3031, ~~2022~~2023 are not necessarily indicative of the results to be expected for the year ending December 31, ~~2022~~2023 or for any future periods.

7Investment income earned on marketable securities held in the Trust Account for the three months ended March 31, 2022 in the amount of $28,951 was reclassified from operating activities to investing activities within the condensed statement of Cash Flows. This reclassification did not impact any other financial statement line items.

Table of Contents

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Table of Contents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, there were no cash equivalents.

Marketable Securities Held in Trust Account

~~The~~As of March 31, 2023 and December 31, 2022, the Company’s portfolio of investments held in the Trust Account are comprised solely of U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Marketable securities are presented on the balance sheet at fair value at the end of the period. Gains and losses resulting from the change in fair value of these investments are included in ~~interest~~investment income on marketable securities held in the Trust Account in the accompanying statements of operations.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on these accounts.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders' equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional capital, in accumulated deficit. For the ~~nine and~~ three-month periods ended ~~September~~March 3031, 2023 and 2022, the Company recorded an accretion of $13,~~714~~094,~~865~~583 and $128,~~297~~951,~~684,~~ respectively, which was recorded in accumulated deficit. ‎

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented on the balance sheets, primarily due to their short-term nature.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.

Table of Contents

Fair Value Measurements

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC 820 approximates the carrying amounts represented on the balance sheets.

The fair value hierarchy is categorized into three levels based on the inputs as follows:

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2: Observable inputs other than Level 1 inputs. Example of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

Table of Contents

Level 3: Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes”. ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the Trust Account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s financial statements.

Net Income (Loss) Per Share ~~of Ordinary Shares~~

The Company complies with accounting and disclosure requirements of ASC 260, “Earnings per Share”. Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period.

The statements of operations include a presentation of income (loss) per Class A ordinary shares subject to possible redemption, and Class A non-redeemable ordinary shares ~~and Class L ordinary shares~~ following the two-class method of income (loss) per share. In order to determine the net income (loss) attributable to Class A ordinary shares subject to possible redemption, and Class A non-redeemable ordinary shares ~~and Class L ordinary shares~~, the Company first considered the total income (loss) allocable to the different classes of shares. This is calculated using the total net income (loss) less any dividends paid and deemed dividends. For purposes of calculating net income (loss) per share, any remeasurement of the accretion to redemption value of the Class A ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders based on ASC 480-10-S99-3A.

As of ~~September~~March 3031, 2023 and December 31, 2022, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the period presented.

Class L ordinary shares will convert into Class A ordinary shares after the initial Business Combination only to the extent certain triggering events occur prior to the 5th anniversary of the initial Business Combination, including three equal triggering events based on the Company’s stock trading at $10, $15, $20 per share. The Company has not considered the effect of the Class L ordinary shares in the calculation of diluted loss per share since the conversion of the Class L ordinary shares is contingent upon the occurrence of future events.

The earnings (loss) per share presented in the statements of operations is based on the following:

‎

Table of Contents

	For the nine-month period ended September 30, 2022				For the three-month period ended September 30, 2022
		Class A ordinary shares subject to possible redemption		Class A non-redeemable ordinary shares		Class A ordinary shares subject to possible redemption		Class A non-redeemable ordinary shares
Basic and diluted net income per share:
Numerator:
Allocation of net income including accretion of temporary equity	$	74,665,030	$	2,532,118	$	25,367,523	$	860,290
Accretion of temporary equity to redemption value		1,714,865		—		1,297,684		—
Allocation of net income	$	76,379,895	$	2,532,118	$	26,665,207	$	860,290
Denominator:
Weighted-average shares outstanding		28,750,000		975,000		28,750,000		975,000
Basic and diluted net income per share	$	2.66	$	2.60	$	0.93	$	0.88

The earnings (loss) per share presented in the statements of operations is based on the following:

	For the period from May 27, 2021 (Inception) through September 30, 2021		For the three-month period ended September 30, 2021
	For the three-month period ended March 31, 2023				For the three-month period ended March 31, 2022
		Class L ordinary shares		Class L ordinary shares
		Class A ordinary shares subject to possible redemption		Class A non-redeemable ordinary shares		Class A ordinary shares subject to possible redemption		Class A non-redeemable ordinary shares
Basic and diluted net loss per share:
Basic and diluted net income (loss) per share:
Numerator:
Net loss	$	(55,860,934)	$	(55,850,310)
Allocation of net income (loss) including accretion of temporary equity	$	(2,074,189)	$	(70,342)	$	34,695,795	$	1,176,640
Denominator:
Accretion of temporary equity to redemption value		3,094,583		—		28,951		—
Weighted-average shares outstanding		12,739,286		12,739,286
Allocation of net income (loss)	$	1,020,394		(70,342)	$	34,724,746	$	1,176,640
Basic and diluted net loss per share	$	(4.38)	$	(4.38)
Denominator:
Weighted-average shares outstanding		28,750,000		975,000		28,750,000		975,000
Basic and diluted net income (loss) per share	$	0.04	$	(0.07)	$	1.21	$	1.21

Recently Adopted Accounting Standards

The Company has considered all other new accounting standards and has concluded that there are no new standards that may have a material impact on the results of operations, financial condition, or cash flows, based on the current information.

Note 3 — Initial Public Offering

On October 1, 2021, the Company consummated its IPO of 28,750,000 Class A ordinary shares (including 3,750,000 Class A ordinary shares pursuant to the underwriters’ exercise in full of the over-allotment option) at a purchase price of $10.00 per ordinary share, generating gross proceeds of $287,500,000.

Note 4 — Private Placement Shares

Following the closing of the IPO, the Company received $9,750,000 from the Sponsor for the issuance of the 975,000 Private Placement Shares at a price of $10.00 per share.

The Private Placement Shares will not be transferable, assignable, or salable until 30 days after the completion of the initial Business Combination and they will not be redeemable by the Company so long as they are held by the Sponsor or its permitted transferees. If the Company does not complete a Business Combination the Private Placement Shares will expire worthless.

Note 5 — Related Party Transactions

Founder Shares

AsOn of June 17, 2021, the Sponsor paid $25,000 on behalf of the Company to cover Company expenses in consideration for 3,194,444 shares of Class B ordinary shares and 9,126,984 shares of Class L ordinary shares (“founder shares”). On September 10, 2021, the Company passed a special resolution to amend the authorized share capital of the Company to $50,000 divided into 464,000,000 Class A ordinary shares, 35,000,000 Class L ordinary shares and 1,000,000 preference shares by (i) redesignating the 6,805,556 unissued Class B ordinary shares into 6,805,556 Class L ordinary shares and (ii) converting into stock the 3,194,444 issued Class B ordinary shares and reconverting and redesignating into 3,194,444 Class L ordinary shares. On September 10, 2021, the securities subscription agreement was amended to provide for the issuance of an additional 417,858 Class L ordinary shares such that, in the aggregate, our sponsor owns 12,739,286 Class L ordinary shares. The number of Class L ordinary shares issued was determined based on the expectation that the Class L ordinary shares would represent 30% of the ordinary shares upon completion of the IPO.

The Sponsor, officers and directors of the Company have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to any founder shares and public shares they hold in connection with the completion of the initial Business Combination, (ii) waive their redemption rights with respect to any founder shares and public shares they hold in connection with a shareholder vote to approve an amendment to the Company amended and restated memorandum and articles of association (as defined below) to modify the substance or timing of the Company’s obligation to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within 24 months from the closing of this offering or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the Trust Account with respect to any founder shares they hold if the

Table of Contents

~~35,000,000~~Company ~~Class~~fails Lto ~~ordinary~~complete ~~shares~~the ~~and~~initial ~~1,000,000~~Business ~~preference~~Combination ~~shares~~within by24 ~~(i)~~months ~~redesignating~~from the ~~6,805,556~~closing ~~unissued~~of ~~Class~~the BIPO ~~ordinary~~or ~~shares~~during ~~into~~any 6Extended Period,~~805,556~~ ~~Class~~although Lthey ~~ordinary~~will ~~shares~~be ~~and~~entitled ~~(ii)~~to ~~converting~~liquidating ~~into~~distribution ~~stock~~from the ~~3,194,444~~Trust ~~issued~~Account ~~Class~~with Brespect ~~ordinary~~to ~~shares~~any ~~and~~public ~~reconverting~~shares ~~and~~they ~~redesignating~~hold ~~into~~if ~~3,194,444~~the ~~Class~~Company Lfails ~~ordinary~~to ~~shares.~~complete Onan ~~September~~initial ~~10,~~Business ~~2021,~~Combination ~~the~~within ~~securities~~such ~~subscription~~time ~~agreement~~period. ~~was~~If ~~amended to provide for~~ the ~~issuance~~Company ofsubmits an ~~additional~~initial ~~417,858~~Business ~~Class~~Combination Lto ~~ordinary~~the ~~shares~~Company’s ~~such~~public ~~that,~~shareholders infor ~~the~~a ~~aggregate~~vote, ~~our~~the ~~sponsor~~Company’s ~~owns~~initial ~~12,739,286~~shareholders ~~Class~~have Lagreed ~~ordinary~~to ~~shares.~~vote ~~The~~their ~~number~~founder ~~of Class L ordinary~~ shares, ~~issued~~their ~~was~~Private ~~determined~~Placement ~~based~~Shares onand ~~the~~any ~~expectation~~public ~~that the Class L ordinary~~ shares ~~would~~purchased ~~represent~~during ~~30%~~or ofafter the ~~ordinary~~IPO ~~shares~~in ~~upon~~favor ~~completion~~ of the ~~IPO~~initial Business Combination.

~~The~~On ~~Sponsor,~~September ~~officers and directors of the Company have entered into a letter agreement with the Company~~10, pursuant to which they have agreed to (i) waive their redemption rights with respect to any Class L ordinary shares and public shares they hold in connection with the completion of the initial Business Combination2021, ~~(ii) waive their redemption rights with respect to any Class L ordinary shares and public shares they hold in connection with a shareholder vote to approve an amendment to~~ the Company also amended ~~and~~its ~~restated~~ memorandum and articles of association (~~as defined below) to modify~~ the ~~substance~~“Amended orand ~~timing~~Restated ofMemorandum ~~the~~and ~~Company’s~~Articles ~~obligation to redeem 100%~~ of ~~the~~Association”). The Company’s ~~public~~Amended ~~shares~~and ifRestated ~~the~~Memorandum ~~Company~~and ~~has~~Articles ~~not~~of ~~consummated~~Association anprovide ~~initial~~that ~~Business Combination within 24 months from~~ the ~~closing~~holders of this offering or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity and (iii) waive their rights to liquidating distributions from the ~~Trust~~founder ~~Account with respect to any Class L ordinary~~ shares ~~they~~have ~~hold if~~ the ~~Company~~right ~~fails~~ to ~~complete~~vote ~~the~~on ~~initial Business Combination within 24 months from~~ the ~~closing~~appointment of ~~the~~directors. ~~IPO~~Holders orof ~~during any Extended Period, although they will be entitled to liquidating distribution from~~ the ~~Trust Account with respect to any~~ public shares ~~they~~are ~~hold~~not ifentitled ~~the Company fails~~ to ~~complete~~vote anon ~~initial Business Combination within such time period. If~~ the ~~Company~~appointment ~~submits~~or anremoval ~~initial~~of ~~Business~~directors ~~Combination~~or tocontinuing the Company’s ~~public~~in ~~shareholders for~~ a ~~vote,~~jurisdiction outside the ~~Company’s~~Cayman ~~initial~~Islands ~~shareholders~~prior ~~have agreed~~ to ~~vote~~consummation ~~their Class L ordinary shares, their Private Placement Shares and any public shares purchased during or after the IPO in favor~~ of the initial Business Combination.

OnThe ~~September~~Sponsor ~~10,~~has ~~2021,~~agreed ~~the~~not ~~Company~~to ~~also~~transfer, ~~amended~~assign ~~its~~or ~~memorandum~~sell ~~and~~(i) ~~articles~~any of ~~association~~their ~~(the~~founder ~~“Amended~~shares and ~~Restated~~any ~~Memorandum~~Class ~~and~~A ~~Articles~~ordinary shares issuable upon conversion thereof until the earlier to occur of: ~~Association”~~(A). ~~The~~eighteen ~~Company’s~~months ~~Amended~~after ~~and~~the ~~Restated~~completion ~~Memorandum~~of ~~and~~the ~~Articles~~initial ofBusiness ~~Association~~Combination, ~~provide~~(B) ~~that~~subsequent to the ~~holders~~initial Business Combination, if the last sale price of the Class LA ordinary shares ~~have~~equals ~~the~~or exceeds $13.00 per share (as adjusted for share sub-divisions, share dividends, right toissuances, ~~vote~~subdivisions, onreorganizations, recapitalizations and the ~~appointment~~like) offor ~~directors.~~any ~~Holders~~20 oftrading ~~the~~days ~~public~~within ~~shares~~any ~~are~~30-trading ~~not~~day ~~entitled~~period tocommencing ~~vote~~at onleast 150 days after the ~~appointment~~initial Business Combination or ~~removal~~(C) ofthe ~~directors~~date oron ~~continuing~~which the Company incomplete a ~~jurisdiction~~liquidation, ~~outside~~merger, ~~the~~share ~~Cayman~~exchange ~~Islands~~or ~~prior~~other tosimilar ~~consummation~~transaction ofafter the initial Business Combination that results in all of the shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; provided, that any Class A ordinary shares issued upon conversion of any founder shares will not be subject to such restrictions on transfer.

The ~~Sponsor~~Company’s ~~has~~Amended ~~agreed~~and ~~not~~Restated toMemorandum ~~transfer,~~and ~~assign~~Articles ~~or sell (i) any~~ of ~~their~~Association ~~Class~~provide Lthat the ~~ordinary~~founder shares ~~and~~will ~~any~~convert into Class A ordinary shares ~~issuable~~after ~~upon~~the ~~conversion~~initial ~~thereof~~Business ~~until~~Combination, only to the ~~earlier~~extent tothe ~~occur~~trading price of: ~~(A)~~the ~~eighteen~~public ~~months~~shares ~~after~~exceeds ~~the~~certain ~~completion~~market ofprice thresholds after the initial Business Combination, ~~(B)~~and ~~subsequent~~before tothe fifth anniversary of the initial Business Combination, ifat ~~the~~a ~~last~~ratio ~~sale~~such ~~price~~that of the number of Class A ordinary shares ~~equals~~issuable orupon ~~exceeds~~conversion ~~$13.00~~of ~~per~~all ~~share~~founder ~~(as~~shares ~~adjusted~~would ~~for~~equal, ~~share~~in ~~sub-divisions,~~the ~~share~~aggregate ~~dividends,~~on ~~right~~an ~~issuances,~~as-converted ~~subdivisions~~basis, would ~~reorganizations~~represent 10%, 20% ~~recapitalizations~~or 30% of ~~and~~ the ~~like~~sum of (i) ~~for~~the ~~any~~total 20number ~~trading~~of ~~days~~all ~~within~~Class A ordinary shares issued and outstanding upon completion of this offering (including any 30over-~~trading~~allotment ~~day~~shares ~~period~~if ~~commencing~~the atunderwriters ~~least~~exercise ~~150~~their ~~days~~over-allotment ~~after~~and without giving effect to any redemptions of any public shares in connection with the initial Business Combination), orplus (Cii) the ~~date~~total onnumber ~~which~~of ~~the~~Class ~~Company~~A ~~complete~~ordinary ashares ~~liquidation,~~issued ~~merger,~~or ~~share~~deemed ~~exchange~~issued or ~~other~~issuable ~~similar~~upon ~~transaction~~conversion ~~after~~of the ~~initial~~founder ~~Business~~shares, ~~Combination~~plus ~~that~~(iii) ~~results~~unless inwaived ~~all~~by ofthe Sponsor, the ~~shareholders~~total ~~having~~number ~~the~~of ~~right~~Class toA ~~exchange~~ordinary ~~their~~shares or equity-linked securities exercisable for or convertible into Class A ordinary shares ~~for~~issued, ~~cash~~deemed issued, ~~securities~~or to be issued, in connection with or ~~other~~in ~~property;~~relation ~~provided~~to the consummation of the initial Business Combination, ~~that~~excluding (x) any Class A ordinary shares ~~issued~~or ~~upon~~equity-linked ~~conversion~~securities ofexercisable ~~any~~for or convertible into Class LA ordinary shares ~~will~~issued, ~~not~~deemed issued, or to be ~~subject~~issued, to ~~such~~any ~~restrictions~~seller in the initial Business Combination, (y) any redemption of public shares in connection with the initial Business Combination or (z) Forward Purchase Shares, based on ~~transfer~~whether the Class A ordinary shares trade at or above $10.00, $15.00 and $20.00 per share, respectively, for any 20 trading days within a 30-trading day period.

~~The~~In ~~Company’s~~addition, ~~Amended~~in ~~and~~the ~~Restated~~event ~~Memorandum~~of ~~and~~any ~~Articles~~liquidation, ofmerger, ~~Association~~share ~~provide~~exchange, reorganization or other similar transaction is consummated after our initial Business Combination (“Strategic Transaction”) that results in all of the ~~Class~~public Lshareholders ~~ordinary~~having ~~shares~~the ~~will~~right ~~convert~~to ~~into~~exchange their Class A ordinary shares ~~after~~for ~~the~~cash, ~~initial~~securities ~~Business~~or ~~Combination~~other property, ~~only~~then, toimmediately before the ~~extent~~consummation ~~the~~of ~~trading~~such ~~price~~Strategic Transaction, all of the ~~public~~then-outstanding founder shares ~~exceeds~~will ~~certain~~automatically ~~market~~convert ~~price~~into ~~thresholds~~Class ~~after~~A ~~the~~ordinary ~~initial~~shares, ~~Business~~contemporaneously ~~Combination~~with ~~and before~~ the ~~fifth~~closing ~~anniversary~~ of ~~the~~such ~~initial~~Strategic ~~Business Combination~~Transaction, at a ratio such that the aggregate number of Class A ordinary shares issuable upon conversion of all ~~Class~~founder Lshares ~~ordinary~~(including ~~shares~~the ~~would~~founder ~~equal,~~shares) in the aggregate on an as-converted basis, would represent ~~10%, 20%~~ orno more than 30% of the sum of (i) the total number of all Class A ordinary shares issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their over-allotment option and without giving effect to any redemptions of any public shares in connection with the initial Business Combination), plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion of the ~~Class~~founder ~~L ordinary~~ shares, plus (iii) unless waived by the Sponsor, the total number of Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, in connection with or in relation to the consummation of the initial Business Combination, excluding (x) any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination, (y) any redemption of public shares in connection with the initial Business Combination or (z) ~~forward~~Forward ~~purchase~~Purchase ~~shares, based on whether the Class A ordinary shares trade at or above $10~~Shares.~~00, $15.00 and $20.00 per share, respectively, for any 20 trading days within a 30-trading day period.~~

InAll ~~addition,~~founder inshares ~~the~~that ~~event~~have ofnot ~~any~~been ~~liquidation,~~converted ~~merger,~~to ~~share~~Class ~~exchange,~~A ~~reorganization~~ordinary orshares ~~other~~on ~~similar~~the ~~transaction~~fifth isanniversary ~~consummated~~of ~~after~~the ~~our~~ initial Business Combination ~~(“Strategic~~will ~~Transaction”)~~be ~~that~~exchanged ~~results~~on insuch ~~all~~date, ofat the ~~public~~Company’s ~~shareholders~~election, ~~having~~for ~~the~~an ~~right~~aggregate ~~to exchange their Class A ordinary shares~~ for ~~cash,~~all ~~securities or other property, then, immediately before the consummation of~~ such ~~Strategic~~founder ~~Transaction,~~shares ~~all~~ of ~~the~~either ~~then-outstanding~~(i) ~~Class~~100 ~~L ordinary shares will automatically convert into~~ Class A ordinary shares, ~~contemporaneously~~or ~~with~~(ii) ~~the closing of such Strategic Transaction~~cash, atin aan ~~ratio~~amount ~~such~~equal ~~that~~to the ~~aggregate~~value ~~number~~ of 100 Class A ordinary shares, ~~issuable~~based ~~upon~~on ~~conversion~~the ofaverage ~~all~~market ~~Class~~price Lof ~~ordinary shares (including the~~ Class LA ordinary shares) inover the ~~aggregate~~period onof anfive ~~as-converted~~trading ~~basis,~~days ~~would~~ending ~~represent~~two notrading ~~more~~days ~~than 30%~~before of the ~~sum~~date of ~~(i) the total number of all Class A ordinary shares issued and outstanding upon~~ exchange.

‎

Table of Contents

~~completion~~The ofCompany ~~this~~accounts ~~offering~~for ~~(including~~the ~~any~~founder ~~over-allotment~~ shares ifas ~~the~~equity ~~underwriters~~linked ~~exercise~~instruments. ~~their~~Based ~~over-allotment~~on ~~option~~the ~~and~~guidance ~~without giving effect to any redemptions of any public shares~~ in ~~connection~~ASC ~~with the initial Business Combination)~~815, ~~plus~~certain ~~(ii)~~adjustments to the ~~total~~settlement ~~number~~amount of ~~Class~~the Afounder ~~ordinary~~ shares ~~issued~~are orbased ~~deemed~~on ~~issued~~a orvariable ~~issuable~~that ~~upon~~is ~~conversion~~not ofan ~~the~~input ~~Class~~to ~~L ordinary shares, plus (iii) unless waived by~~ the ~~Sponsor,~~fair ~~the~~value ~~total number~~ of ~~Class~~a ~~A ordinary shares or equity~~“fixed-~~linked securities exercisable~~ for-fixed” oroption ~~convertible~~as ~~into~~defined ~~Class~~under AASC ~~ordinary~~815-40. ~~shares~~The ~~issued,~~founder ~~deemed issued, or to be issued, in connection with or in relation to the consummation of the initial Business Combination, excluding (x) any Class A ordinary~~ shares orare ~~equity-linked~~recorded ~~securities~~as ~~exercisable~~liabilities ~~for~~as orthese ~~convertible into Class A ordinary~~ shares ~~issued,~~are ~~deemed~~not ~~issued,~~considered orindexed to ~~be issued, to any seller in~~ the ~~initial~~Company’s ~~Business~~own ~~Combination,~~stock ~~(y)~~and ~~any~~not ~~redemption~~eligible offor ~~public~~an ~~shares~~exception infrom ~~connection~~derivative ~~with the initial Business Combination or (z) forward purchase shares~~accounting.

All Class L ordinary shares that have not been converted to Class A ordinary shares on the fifth anniversary of the initial Business Combination will be exchanged on such date, at the Company’s election, for an aggregate for all such Class L ordinary shares of either (i) 100 Class A ordinary shares or (ii) cash, in an amount equal to the value of 100 Class A ordinary shares, based on the average market price of Class A ordinary shares over the period of five trading days ending two trading days before the date of exchange.

The Company accounts for the Class L ordinary shares as equity linked instruments. Based on the guidance in ASC 815, certain adjustments to the settlement amount of the Class L ordinary shares are based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC 815-40. The Class L ordinary shares are recorded as a liability as these shares are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting.

Promissory Note - Related Party

The Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. This loan is non-interest bearing, unsecured and due at the earlier of January 31, 2022, or the closing of the IPO. On October 5, 2021, the $300,000 outstanding on this note was repaid in full. The Company can no longer borrow under this facility.

Related Party Loans

In order to finance working capital deficiencies or transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes an initial Business Combination, the Company will repay such loaned amounts out of the proceeds of the Trust Account released to it. Otherwise, such loans would be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $2,000,000 of such loans may be convertible into shares, at a price of $10.00 per ~~shares~~share at the option of the lender. Such shares would be identical to the Private Placement Shares. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the Company had no Working Capital Loans.

Additionally, on November 14, 2022, the Sponsor provided a ~~firm~~commitment letter for funding of up to $800,000 to the Company (the “2022 Commitment Letter”), which was subsequently terminated on February 9, 2023 whereby the Sponsor provided a new commitment letter (the “February Commitment Letter”) for funding of up to the same dollar amount to the Company. On May 5, 2023, the February Commitment Letter was terminated and the Sponsor provided a new commitment letter for funding of up to $800,000 to the Company (the “Commitment Letter”) to be drawn, as needed, over the course of 13 months from the date of the ~~letter~~Commitment Letter to fund working capital deficiencies or finance transaction costs in connection with aan initial Business Combination.

Administrative Services Agreement

On October 1, 2021, the Company entered into an agreement that provides that, subsequent to the closing of the IPO and continuing until the earlier of the Company’s consummation of an initial Business Combination or the Company’s liquidation, the Company will pay the Sponsor a total of $10,000 per month for office space, secretarial, due diligence and administrative services. For the ~~nine and~~ three-month ~~period~~periods ended ~~September~~March 3031, 2023 and 2022, the Company incurred $9030,000 ~~and~~for ~~$30,000,~~each ~~respectively~~period, pursuant to this agreement which has been included in the general and administrative expenses in the accompanying statements of operations. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, no liability regarding this agreement was outstanding.

Table of Contents

Forward Purchase Agreement

On October 1, 2021, and in connection with the IPO, the Company entered into a Forward Purchase Agreement with the Sponsor, pursuant to which the Sponsor committed to purchase from the Company 5,000,000 forward purchase shares (the “Forward Purchase Shares”), at a price of $10.00 per Forward Purchase Share, for an aggregate purchase price of $50,000,000 in a private placement to close substantially concurrently with the closing of an initial Business Combination. The obligations under the Forward Purchase Agreement will not depend on whether any Class A ordinary shares are redeemed by public shareholders. The Class A ordinary shares issuable pursuant to the Forward Purchase Agreement will be identical to the Class A ordinary shares sold in the IPO, except that the Sponsor will have certain registration rights, and the Class A ordinary shares will not be eligible for redemption in connection with an initial Business Combination.

Note 6 — Derivative Financial Instruments

Class L ~~Ordinary~~ordinary ~~Shares~~shares derivative liability

The Class L ordinary shares are accounted for as a liability in accordance with ASC 815 and presented as a derivative liability on the balance sheets. The derivative liability was measured at fair value as of September 10, 2021 (date on which the Company amended its memorandum and articles of association) and will be evaluated on a recurring basis, with changes in fair value presented within fair value of derivative liability in the statements of operations.

~~The~~‎ ~~following table presents a summary of the changes in the fair value of the Class L ordinary shares derivative liability as of September 30, 2022:~~

	Class L ordinary shares derivative liability
Fair value of Class L ordinary shares, December 31, 2021	$	84,257,215
Changes in fair value during the nine-month period		(78,251,009)
Fair value of Class L ordinary shares, September 30, 2022	$	6,006,206

Table of Contents

The following table presents a summary of the changes in the fair value of the Class L ordinary shares derivative liability as of March 31, 2023 and 2022:



	Class L ordinary shares derivative liability
Fair value of Class L ordinary shares, December 31, 2022	$	3,421,120
Changes in fair value during the period		1,710,592
Fair value of Class L ordinary shares, March 31, 2023	$	5,131,712


	Class L ordinary shares derivative liability
Fair value of Class L ordinary shares, December 31, 2021	$	84,257,215
Changes in fair value during the period		(36,294,697)
Fair value of Class L ordinary shares, March 31, 2022	$	47,962,518

The amounts of changes in the fair value on derivative instruments are reported in the statements of operations.

The following table presents the Company's fair value hierarchy for assets and liabilities measured at fair value on a recurring basis as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022:

	As of September 30, 2022
	As of March 31, 2023
	Level 1		Level 2		Level 3		Total
Assets
Marketable securities held in Trust Account	$	~~289~~294,~~220~~747,~~819~~472	$	—	$	—	$	~~289~~294,~~220~~747,~~819~~472
Total Assets	$	~~289~~294,~~220~~747,~~819~~472	$	—	$	—	$	~~289~~294,~~220~~747,~~819~~472
Liabilities
Class L ordinary shares derivative liability	$	—	$	—	$	65,~~006~~131,~~206~~712	$	65,~~006~~131,~~206~~712
Total Liabilities	$	—	$	—	$	65,~~006~~131,~~206~~712	$	65,~~006~~131,~~206~~712

	As of December 31, 2021
	As of December 31, 2022
	Level 1		Level 2		Level 3		Total
Assets
Marketable securities held in Trust Account	$	~~287~~291,~~505~~652,~~954~~889	$	—	$	—	$	~~287~~291,~~505~~652,~~954~~889
Total Assets	$	~~287~~291,~~505~~652,~~954~~889	$	—	$	—	$	~~287~~291,~~505~~652,~~954~~889
Liabilities
Class L ordinary shares derivative liability	$	—	$	—	$	843,~~257~~421,~~215~~120	$	843,~~257~~421,~~215~~120
Total Liabilities	$	—	$	—	$	843,~~257~~421,~~215~~120	$	843,~~257~~421,~~215~~120

There were no transfers to and from Levels 1, 2 and 3 during the three-month period ended March 31, 2023 and the year ended December 31, 2022.

The Company measured the Class L ordinary shares derivative liability at fair value determined at Level 3. In order to capture the market conditions associated with the Class L ordinary shares derivative liability, the Company applied an approach that incorporated a Monte Carlo simulation, which involved random iterations of future stock-price paths over the contractual life of the Class L ordinary shares. Based on assumptions regarding potential changes in control of the Company, and the probability distribution of outcomes, the payoff to the holder was determined based on the achievement of the various market thresholds within each simulated path. The present value of the payoff in each simulated trial is calculated, and the fair value of the liability is determined by taking the average of all present values.

‎

Table of Contents

~~There~~The ~~were~~key noinputs ~~transfers~~into tothe ~~and~~Monte-Carlo ~~from~~simulation ~~Levels~~model 1,for 2Class ~~and~~L 3ordinary ~~during~~shares ~~the~~derivative ~~nine~~liability ~~and~~were ~~three-month~~as ~~periods~~follows, ~~ended~~as ~~September~~of 30March 31, 2023 and December 31, 2022.:


Input	March 31, 2023		December 31, 2022
Risk-free interest rate		3.59%		3.98%
Expected term		5.25 years		5.50 years
Expected volatility		5.48%		5.27%
Stock price⁽¹⁾	$	9.92	$	9.80
Dividend yield		0.0 %		0.0 %

The key inputs into the Monte-Carlo simulation model for Class L ordinary shares were as follows, as of September 30, 2022 and December 31, 2021:

Input	September 30, 2022		December 31, 2021
Risk-free interest rate		4.03%		1.34%
Expected term		5.75 years		6.00 years
Expected volatility		5.5%		18.0%
Stock price(1)	$	9.35	$	11.56
Dividend yield		0.0 %		0.0 %

(1) Traded stock price adjusted to reflect market expectations of success.

Note 7 — Commitments and Contingencies

Registration and Shareholder Rights

The holders of the ~~Class~~founder ~~L ordinary~~ shares and Private Placement Shares that may be issued upon conversion of Working Capital Loans have registration rights that require us to register a sale of any of the Company’s securities held by them (in the case of the ~~Class~~founder ~~L ordinary~~ shares, only after conversion to the Class A ordinary shares) pursuant to a registration rights agreement signed at the closing of the IPO (the “Registration Rights Agreement”). These holders are entitled to make up to three demands, excluding short form registration demands, that we register such securities for sale under the Securities Act. In addition, these holders have certain “piggy-back” registration rights to include such securities in other registration statements filed by us and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act.

Underwriting Agreement

The Company granted the underwriters a 45-day option to purchase up to 3,750,000 additional Class A ordinary shares to cover any over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On September 29, 2021, the underwriters exercised their over-allotment option in full.

On October 1, 2021, the Company paid underwriting discounts and commissions of $5,750,000 in the aggregate. Additionally, a deferred underwriting discounts and commissions of $10,062,500, will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.

~~During~~As ~~September~~of December 31, 2022, ~~two~~all four underwriters of the ~~four~~IPO ~~underwriters~~ waived their entitlement to deferred underwriting discounts and commissions. ~~Deferred~~The ~~underwriting discounts and commissions was reduced to~~ $710,~~546~~062,~~875,~~500 ~~with the $2,515,625~~ waiver ~~being~~was recognized in accumulated deficit.

Investment Management Trust Agreement

In connection with the IPO, the Company entered into an investment management trust agreement pursuant to which a portion of the proceeds of the IPO and the sale of the Private Placement Shares were delivered and are to be held in the Trust Account for the benefit of the Company and the holders of the shares issued in connection with the IPO.

Table of Contents

Note 8 — Shareholders’ Equity (Deficit)

Preferred Shares

The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, no preferred shares were issued or outstanding.

Class A Ordinary Shares

The Company is authorized to issue 464,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, there were 29,725,000 Class A ordinary shares issued and outstanding, 28,750,000 of which are classified as temporary equity.

‎

Table of Contents

Note 9 — General and administrative expenses

For the nine-month period ended September 30, 2022

For the three-month period ended September 30, 2022

For the period from May 27, 2021‎(Inception) through September 30, 2021

For the three-month period ended September 30, 2021

For the three-month period ended March 31, 2023

For the three-month period ended March 31, 2022

Insurance

~~643~~214,~~781~~594

214,~~593~~594

—

Other expenses

~~410~~219,~~080~~345

99207,~~431~~668

~~10,624~~

—

General and administrative expenses

1433,~~053,861~~939

~~314~~422,~~024~~262

~~10,624~~

—

‎

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to MELI Kaszek Pioneer Corp, references to our “management” or our “management team” refer to our officers, references to the “Sponsor” refer to MELI Kaszek Pioneer Sponsor LLC, a Cayman Islands limited liability company. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this Quarterly Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors discussed elsewhere in this Quarterly Report on Form 10-Q, including under Part II, Item 1A, “Risk Factors,” as well as those factors described in the section entitled “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the Securities and Exchange Commission (the “SEC”) on ~~February~~March 176, 2023, as amended by Amendment No. 1 on Form 10-K/A for the year ended December 31, 2022 on May 8, 2023, and in our other SEC filings. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Overview

We are a blank check company incorporated on May 27, 2021 under the laws of the Cayman Islands and formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not identified any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions directly or indirectly, with respect to identifying any business combination target. We intend to effectuate our initial Business Combination (the “Business Combination”) using cash from the proceeds of our initial public offering (the “~~Initial Public Offering~~IPO”) and the cash from the private placement of the private placement shares (~~as defined below) (~~pursuant to the Private Placement Shares Purchase Agreement entered into in connection with the ~~Initial Public Offering~~IPO) (the “Private Placement”), the proceeds of the sale of our securities in connection with our initial Business Combination (pursuant to the forward purchase agreement entered into in connection with the ~~Initial~~IPO ~~Public Offering~~ (the “Forward Purchase Agreements”) or other forward purchase agreements or backstop agreements we may enter into following the consummation of our ~~Initial~~IPO ~~Public Offering~~ or otherwise), our capital stock, debt or a combination of cash, stock and debt.

The registration statement for our ~~Initial~~IPO ~~Public Offering~~ was declared effective by the SEC on September 28, 2021. On October 1, 2021, we consummated our ~~Initial~~IPO ~~Public Offering~~ of 28,750,000 Class A ordinary shares (the “Class A ordinary shares”), which includes the exercise in full of the underwriters’ option to purchase an additional 3,750,000 shares at $10.00 per share, generating gross proceeds of $287,500,000. Simultaneously with the consummation of the ~~Initial Public Offering~~IPO, we consummated the sale of 975,000 shares (the “Private Placement Shares”), at a price of $10.00 per share, generating aggregate gross proceeds to the Company of $9,750,000 ~~which~~that was received prior to the consummation of the ~~Initial Public Offering~~IPO.

Transaction costs of the ~~Initial~~IPO ~~Public Offering~~ amounted to $16,709,861 consisting of $5,750,000 of underwriting discounts and commissions, $10,062,500 of deferred underwriting discounts and commissions, and $897,361 of other offering costs. ~~During~~As ~~September~~of ~~2022~~December ~~two~~31, of2022 ~~the~~all four underwriters waived their entitlement to the deferred underwriting discounts and commissions. ~~As a result, the underwriting discounts and commissions amounted to $7,546,875.~~

Table of Contents

Following the closing of the ~~Initial Public Offering~~IPO, a total of $287,500,000 was placed in a U.S.-based trust account (the “Trust Account”), with Continental Stock Transfer & Trust Company acting as trustee. The proceeds held in the Trust Account have been invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations. Except for the withdrawal of interest to pay our taxes, none of the funds held in trust will be released from the Trust Account until the earliest of (i) the completion of our initial Business Combination, (ii) the redemption of our public shares if we are unable to complete our initial Business Combination within 24 months from the closing of the ~~Initial Public Offering~~IPO, subject to applicable law, and (iii) the redemption of our public shares properly submitted in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association to modify the substance or timing of our obligation to redeem 100% of our public shares if we have not consummated an initial Business Combination within 24 months from the ~~Initial~~IPO ~~Public Offering~~ or with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity.

Business Combination

If we are unable to complete a Business Combination within 24 months from the closing of the ~~Initial~~IPO ~~Public Offering~~ (the “Combination Period”), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account (as defined below), including ~~interest~~investment ~~earned~~income on the funds held in the Trust Account (as defined below) and not previously released to us to pay our taxes (less up to $100,000 of ~~interest~~investment income to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case, to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

The issuance of additional shares in connection with a Business Combination to the owners of the target or other investors:

may significantly dilute the equity interest of investors in the ~~Initial Public Offering~~IPO;

may subordinate the rights of holders of Class A ordinary shares if preferred shares are issued with rights senior to those afforded our Class A ordinary shares;

could cause a change in control if a substantial number of shares of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and

may adversely affect prevailing market prices for our Class A ordinary shares.

Similarly, if we issue debt securities or otherwise incur significant debt to bank or other lenders or the owners of a target, it could result in:

default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;

our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;

our inability to pay dividends on our Class A ordinary shares;

Table of Contents

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

We expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

As of ~~September~~March 3031, ~~2022~~2023, we had not commenced any operations nor generated any revenues. All activity for the period ended ~~September~~March 3031, ~~2022~~2023 relates to our search for a target to consummate a Business Combination. We will not generate any operating revenues until after the completion of a Business Combination, at the earliest. We will generate non-operating income in the form of ~~gain on~~ investment ~~(net),~~income ~~dividends~~on ~~and~~marketable ~~interest~~securities held in the Trust Account (as defined below). We expect to incur increased expenses, as compared to the period before our ~~Initial Public Offering~~IPO, as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the ~~nine~~three-month period ended ~~September~~March 3031, ~~2022~~2023, we had a net income of $78950,~~912~~052,~~013,~~ consisting of $13,~~053~~094,~~861~~583 of ~~general~~investment ~~and~~income ~~administrative expenses ($643,781 corresponding to insurance expenses), $1,714,865 of interest~~ on marketable securities held in Trust Account ~~and~~partially ~~changes~~offset inby ~~the value of the Class L ordinary shares derivative liability of~~ $78,251,009. For the three-month period ended September 30, 2022, we had a net income of $27,525,497, consisting of $314,024 of general and administrative expenses ($214,593 corresponding to insurance expenses), $1,~~297~~710,~~684~~592 of ~~interest on marketable securities held in Trust Account and~~ changes in the value of the Class L ordinary shares derivative liability ofand $26433,~~541,837.~~939 ~~For the period from May 27, 2021 (inception) through September 30, 2021, we had a net loss~~ of ~~$55,860,934, consisting of $10,624 of~~ general and administrative expenses, ($54214,~~956,475~~594 of ~~financing~~which ~~expense~~related onto ~~derivative~~insurance ~~liabilities and $893,835 of changes in the value of the Class L ordinary shares derivative liability of~~expenses). For the three-month period ended September 30, 2021, we had a net loss of $55,850,310, consisting of $54,956,475 of financing expense on derivative liabilities and $893,835 of changes in the value of the Class L ordinary shares derivative liability.

For the three-month period ended March 31, 2022, we had a net income of $35,901,386, consisting of changes in the value of the Class L ordinary shares derivative liability of $36,294,697 and $28,951 of investment income on marketable securities held in Trust Account partially offset by $422,262 of general and administrative expenses ($214,594 of which related to insurance expenses).

Liquidity and Capital Resources

On October 1, 2021, we consummated our ~~Initial~~IPO ~~Public Offering~~ of 28,750,000 Class A ordinary shares, which includes the exercise in full of the underwriters’ option to purchase an additional 3,750,000 Class A ordinary shares at $10.00 per share, generating gross proceeds of $287,500,000. Simultaneously with the consummation of the ~~Initial Public Offering~~IPO, we consummated the sale of 975,000 Private Placement Shares, at a price of $10.00 per share, generating aggregate gross proceeds to the Company of $9,750,000.

Transaction costs of the ~~Initial~~IPO ~~Public Offering~~ amounted to $16,709,861 consisting of $5,750,000 of underwriting discounts and commissions, $10,062,500 of deferred underwriting discounts and commissions, and $897,361 of other offering costs. ~~During~~As ~~September~~of ~~2022~~December ~~two~~31, of2022 ~~the~~all four underwriters ~~have~~ waived their entitlement to the deferred underwriting discounts and commissions. ~~As a result, the underwriting discounts and commissions amounted to $7,546,875.~~

Upon closing of the ~~Initial Public Offering~~IPO, a total of $287,500,000 was placed in the Trust Account. The proceeds held in the Trust Account have been invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations.

As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, we had cash outside our Trust Account of $~~815~~407,~~520~~814 and $1669,~~259,439~~889. All remaining cash from the ~~Initial~~IPO ~~Public Offering~~ is held in the Trust Account and is generally unavailable for use prior to an initial Business Combination.

As‎ of September 30, 2022 and December 31, 2021 we had working capital of $277,343,053 and of $2,085,395 (not taking into account any tax obligations), respectively. As of September 30, 2022, the working capital calculation includes the investments held in the Trust Account as part of current assets and the Class L ordinary shares derivative liability and the deferred underwriting discounts and

Table of Contents

~~commissions~~As of March 31, 2023 and December 31, 2022 we had working capital of $290,443,091 and of $289,493,039 (not taking into account any tax obligations), respectively. As of March 31, 2023, the working capital calculation includes the investments held in the Trust Account as part of current assets and the Class L ordinary shares derivative liability as part of the current liabilities. The Company classified the investments held in the Trust Accounts as a current asset as the Company has less than 12 months from the balance sheet date to consummate aan initial Business Combination, at which point, if the Company did not find a ~~Business Combination partner~~target, the Company would cease to exist, and the funds would be liquidated from the Trust Account. The Company classified the Class L ordinary shares derivative liability ~~and the deferred underwriting discounts and commissions~~ as current ~~liabilities~~liability as the Company has less than 12 months from the balance sheet date to consummate aan initial Business Combination, at which point, if the Company did not find a ~~Business Combination partner~~target, the Company would cease to exist, and the Class L ordinary shares derivative liability would not be converted~~, and the deferred underwriting discounts and commissions would not be paid as the fees owed are contingent upon a successful Business Combination~~.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing ~~interest~~investment ~~earned~~income on the Trust Account ~~(excluding deferred underwriting discounts~~ and ~~commissions) and~~ the proceeds from the sale of the ~~forward~~Forward ~~purchase~~Purchase ~~shares~~Shares, to complete our initial Business Combination. Our annual income tax obligations will depend on the amount of interest and other income earned on the amounts held in the ~~trust~~Trust ~~account~~Account. We expect the ~~interest~~investment ~~earned~~income on the amount in the ~~trust~~Trust ~~account~~Account will be sufficient to pay our income taxes. To the extent that our equity or debt is used, in whole or in part, as consideration to complete our initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

In order to finance working capital deficiencies or transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes an initial Business Combination, the Company will repay such loaned amounts out of the proceeds of the Trust Account released to it in accordance with the Company’s amended and restated memorandum and articles of association. Otherwise, such loans would be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $2,000,000 of such loans may be convertible into shares at the option of the lender, at a price of $10.00 per ~~shares at the option of the lender~~share. Such shares would be identical to the Private Placement Shares. Additionally, on November 14, 2022, the Sponsor provided a commitment letter for funding of up to $800,000 to the Company (the “2022 Commitment Letter”), which was subsequently terminated on February 9, 2023 whereby the Sponsor provided a new commitment letter (the “February Commitment Letter”) for funding of up to the same dollar amount to the Company. On May 5, 2023, the February Commitment Letter was terminated and the Sponsor provided a new commitment letter for funding of up to $800,000 to the Company (the “Commitment Letter”) to be drawn ~~against~~, as needed, over the course of 13 months from the date of the ~~commitment~~Commitment ~~letter~~Letter to fund working capital deficiencies or finance transaction costs in connection with aan initial Business Combination.

We do not believe we will need to raise additional funds or draw on the Commitment Letter in order to meet the expenditures required for operating our business prior to our initial Business Combination. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business Combination.

Moreover, we may need to obtain additional financing to complete our initial Business Combination, either because the transaction requires more cash than is available from the proceeds held in our Trust Account and from the sale of the Forward Purchase Shares or because we become obligated to redeem a significant number of our public shares upon completion of the Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial Business Combination. If we are unable to complete our initial Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our initial Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

The following table presents our cash flows from operating activities for the following periods:

Net cash and restricted cash (used in) provided by:	For the nine-month period ended September 30, 2022		For the three-month period ended September 30, 2022		For the period from May 27, 2021‎(Inception) through September 30, 2021		For the three-month period ended September 30, 2021
Net cash (used in) provided by:	For the three-month period ended March 31, 2023		For the three-month period ended March 31, 2022
Operating activities	$	~~(443~~2,~~919)~~832,508	$	(~~107~~200,~~029~~997)	$	—	$	—
Financing activities		—		—		9,755,780		9,755,780
Investing activities		(3,094,583)		(28,951)
Net change in cash and restricted cash	$	(443,919)	$	(107,029)	$	9,755,780	$	9,755,780
Financing activities		—		—
Net change in cash	$	(262,075)	$	(229,948)

Table of Contents

~~Cash~~As ~~used~~of inMarch ~~operating~~31, ~~activities~~2023, ~~consists~~the of net income ~~adjusted~~of ~~for~~$950,052 ~~certain~~was affected by a non-cash ~~items,~~loss ~~and~~on the ~~effect~~change ~~of changes~~ in ~~working~~fair ~~capital.~~value ~~Net~~of ~~cash~~the ~~used~~Class inL ~~operating~~ordinary ~~activities~~shares inderivative ~~the~~liability ~~nine~~of $1,710,592 and ~~three-month~~a ~~periods~~net ~~ended~~increase ~~September~~in ~~30,~~operating ~~2022~~assets ~~resulted~~and ~~mainly~~liabilities ~~from~~of ~~a decrease in prepaid expenses~~$171,864. Net cash ~~provided~~used byin ~~financing~~investing activities for the ~~period from May 27, 2021 (inception) through September 30, 2021 and for the~~ three-month period ended ~~September~~March 3031, ~~2021~~2023, was ~~primarily~~$3,094,583, from the ~~prepaid~~reinvestment ~~stock~~of ~~subscription.~~the investment income into Trust Account.

As of March 31, 2022, the net income of $35,901,386 was affected by a non-cash gain on the change in fair value of the Class L ordinary shares derivative liability of $36,294,697 and a net increase in operating assets and liabilities of $192,314. Net cash used in investing activities for three-month period ended March 31, 2022, was $28,951, from the reinvestment of the investment income into Trust Account.

Commitments and Contractual Obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as described below.

Registration Rights

The holders of the Class L ordinary shares, and Private Placement Shares ~~and private placement shares~~ that may be issued upon conversion of Working Capital Loans have registration rights that require us to register a sale of any of our securities held by them (in the case of the Class L ordinary shares, only after conversion to our Class A ordinary shares) pursuant to a registration rights agreement at the closing of the ~~Initial~~IPO ~~Public Offering~~ (the “Registration Rights Agreement”). These holders are entitled to make up to three demands, excluding short form registration demands, that we register such securities for sale under the Securities Act. In addition, these holders will have certain “piggy-back” registration rights to include such securities in other registration statements filed by us and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act.

Pursuant to the Forward Purchase ~~Agreements~~Agreement, we agreed that we will use our commercially reasonable efforts to file within 30 calendar days after the closing of our initial Business Combination a registration statement with the SEC for a secondary offering of the ~~forward~~Forward ~~purchase~~Purchase ~~shares~~Shares (as defined below) owned by our Sponsor or the forward transferees, respectively, and use our commercially reasonable efforts to cause such registration statement to be declared effective as soon as practicable after such completion.

However, the Registration Rights Agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Class L ordinary shares, any Class A ordinary shares issuable upon conversion thereof and the ~~forward~~Forward ~~purchase~~Purchase ~~shares~~Shares, until the earlier of (A) eighteen months after the completion of our initial Business Combination, or (B) subsequent to our initial Business Combination, if the last sale price of the Class A ordinary shares equals or exceeds $13.00 per share (as adjusted for share sub-divisions, share dividends, right issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial Business Combination, or (C) following the completion of our initial Business Combination, such future date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property, and (ii) in the case of the private placement shares, 30 days after the completion of our initial Business Combination. We will bear the costs and expenses of filing any such registration statements.

Administrative Services Agreement

On October 1, 2021, the Company entered into an agreement that provides that, subsequent to the closing of the ~~Initial~~IPO ~~Public Offering~~ and continuing until the earlier of the Company’s consummation of an initial Business Combination or the Company’s liquidation, the Company pays the Sponsor a total of $10,000 per month for office space, secretarial, due diligence and administrative services.

Forward Purchase Agreements

In connection with the ~~Initial Public Offering~~IPO, we entered into the Forward Purchase Agreement with the Sponsor, pursuant to which the Sponsor committed to purchase from the Company 5,000,000 forward purchase shares (the “Forward Purchase Shares”), at a price of $10.00 per Forward Purchase Share, for an aggregate purchase price of $50,000,000 in a private placement to close substantially concurrently with the closing of an initial Business Combination. The obligations under the Forward Purchase Agreement will not depend on whether any Class A ordinary shares are redeemed by public shareholders. The Class A ordinary shares issuable pursuant to the Forward Purchase Agreement will be identical to the Class A ordinary shares sold in the ~~Initial Public Offering~~IPO, except that the Sponsor will have certain registration rights, as described herein, and the Class A ordinary shares will not be eligible for redemption in connection with an initial Business Combination.

‎

Table of Contents

Underwriting Agreement

Upon the closing of the ~~Initial~~IPO ~~Public Offering~~ we paid $5,750,000 (accounting for the exercise of the underwriters’ over-allotment option in full) to the underwriters for underwriting discounts and commissions. Additionally, the underwriters ~~are~~were entitled to a deferred fee of $10,062,500 (accounting for the exercise of the underwriters’ over-allotment option in full), which ~~will~~would be payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete an initial Business Combination, subject to the terms of the underwriting agreement.

~~During~~As ~~September~~of December 31, 2022, ~~two~~all four underwriters of the ~~four~~IPO ~~underwriters~~ waived their entitlement to this deferred underwriting discounts and commissions. ~~Deferred underwriting discounts and commissions was reduced to $7,546,875, with the $2,515,625 waiver being recognized in accumulated deficit.~~

Off-Balance Sheet Financing Arrangements

As of ~~September~~March 3031, 2023 and December 31, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

Critical Accounting Estimates

The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting estimates:

Class L ordinary shares derivative liability

The Class L ordinary shares are accounted for as a liability in accordance with Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging” and presented as a derivative liability on the balance sheets. The derivative liability was measured at fair value as of September 10, 2021 and will be evaluated on a recurring basis, with changes in fair value presented within fair value of derivative liability in the statements of operations. In order to capture the market conditions associated with the Class L ordinary shares liability, the Company applied an approach that incorporated a Monte Carlo simulation, which involved random iterations of future stock-price paths over the contractual life of the Class L ordinary shares. Based on assumptions regarding potential changes in control of the Company, and the probability distribution of outcomes, the payoff to the holder was determined based on the achievement of the various market thresholds within each simulated path. The present value of the payoff in each simulated trial is calculated, and the fair value of the liability is determined by taking the average of all present values.

The inputs used as of ~~September~~March 3031, ~~2022~~2023, were as follow: risk-free rate of 43.0359%; expected term of 5.7525 years; expected volatility of 5.548% and adjusted stock price of $9.3592.

The inputs used as of December 31, ~~2021,~~2022 were as follow: risk-free rate of 13.3498%; expected term of 65.0050 years; expected volatility of 185.027% and adjusted stock price of $119.5680.

Recent Accounting Standards

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Table of Contents

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our ~~Initial~~IPO ~~Public Offering~~ or until we are no longer an “emerging growth company,” whichever is earlier.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Co-Chief Executive Officers, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our Co-Chief Executive Officers, our management evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”). Based upon that evaluation, our Co-Chief Executive Officers concluded that, as of the Evaluation Date, our disclosure controls and procedures were ~~not~~ effective ~~due to the material weakness in internal control over financial reporting that as we previously reported in our Current Report on Form 8-K filed with the SEC on November 21, 2022~~.

Remediation of Previously Disclosed Material Weaknesses

As previously reported in our Current Report on Form 8-K filed with the SEC on November 21, 2022, our management identified a material weakness in our internal control over financial reporting due to the improper determination of our Earnings Per Share as of September 30, 2021 and December 31, 2021, which is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the relevant period.

Since the fourth quarter of 2022, our management implemented our previously disclosed remediation plan which included expanding and improving our review process for complex securities and related accounting standards, enhancing access to accounting literature and identifying third-party professionals with whom to consult regarding complex accounting applications.

Our management completed the testing necessary to conclude that the material weakness was remediated as of March 31, 2023.

Changes in Internal Control over Financial Reporting

There ~~was~~were no ~~change~~changes in our internal control over financial reporting (as such term is defined in ~~Rules~~Rule 13a-15(f) and 15d-15(f) ofunder the Exchange Act) ~~that occurred~~ during the three-month period ~~covered~~ended byMarch 31, ~~this~~2023 ~~Quarterly Report on Form 10-Q~~ that ~~has~~have materially affected, or isare reasonably likely to materially affect, our internal control over financial reporting.‎

Our internal control over financial reporting did not result in the proper determination of our EPS as of September 30, 2021 and December 31, 2021, which is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the relevant period.

On September 10, 2021, the Company amended certain terms of the Class L ordinary shares (the “Class L Shares”) held by the Sponsor. As a result of the amendment, the Class L Shares no longer met the requirement to be classified in equity and was recorded as a liability. The Company did not consider the Class L Shares in its calculation of basic and diluted net loss per share as of September 30, 2021 and December 31, 2021. Management re-evaluated this conclusion and determined that basic and diluted net loss per share should be calculated by attributing net loss for the period from May 27, 2021 (inception) to September 30, 2021 to the Class L Shares, which represent the Sponsor’s existing equity interest in the Company and the only class of share outstanding for that period. The net loss for the period from October 1, 2021 to December 31, 2021 will be attributed to the Class A ordinary shares subject to possible redemption and the Class A non-redeemable ordinary shares, based on the respective participation rights of those shares for that period. The Class L ordinary shares had no participation rights effective October 1, 2021.

Management has implemented remediation steps to address the material weakness and to improve our internal control over financial reporting. Specifically, our plans at this time are to expand and improve our review process for complex securities and related accounting standards. We also plan to further improve this process by enhancing access to accounting literature and identifying of third-party professionals with whom to consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

None.

ITEM 1A. RISK FACTORS.

Except as set forth below, there have been no material changes to the risk factors described in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the SEC on ~~February~~March 176, 2023, as amended by Amendment No. 1 on Form 10-K/A for the year ended December 31, 2022 on May 8, 2023.

~~Changes~~Adverse indevelopments ~~laws~~affecting orthe ~~regulations,~~financial ~~including~~services ~~different~~industry, orsuch ~~heightened~~as ~~rules~~actual events or ~~requirements~~concerns ~~promulgated~~involving ~~by the SEC~~liquidity, defaults or anon-performance ~~failure~~by tofinancial ~~comply~~institutions ~~with~~or ~~any~~transactional ~~laws and regulations~~counterparties, ~~may~~could adversely affect our ~~business,~~current ~~including~~and ~~our~~projected ~~ability~~business tooperations ~~negotiate~~ and ~~complete~~financial ~~our~~condition ~~initial Business Combination~~ and results of operations.

WeEvents ~~are~~involving ~~subject~~limited toliquidity, ~~laws~~defaults, ~~and~~non-performance ~~regulations.~~or Inother ~~particular,~~adverse wedevelopments ~~are~~that ~~required~~affect tofinancial ~~comply~~institutions, ~~with~~transactional ~~certain~~counterparties ~~SEC~~or ~~and~~ other ~~legal~~companies ~~requirements~~in ~~related~~the tofinancial aservices ~~potential~~industry ~~business~~or ~~combination.~~the ~~Compliance~~financial ~~with~~services industry generally, ~~and~~or ~~monitoring~~concerns or rumors about any events of these kinds or other similar risks, ~~applicable~~have ~~laws~~in ~~and~~the ~~regulations~~past and may bein ~~difficult,~~the ~~time~~future ~~consuming~~lead ~~and~~to ~~costly~~market-wide liquidity problems. ~~Those~~Most ~~laws~~recently, ~~and~~on ~~regulations~~March ~~and~~10, ~~their~~2023, ~~interpretation~~Silicon ~~and~~Valley ~~application~~Bank ~~may~~(“SVB”) ~~also~~was ~~change~~closed ~~from~~by ~~time~~the toCalifornia ~~time~~Department of Financial Protection and ~~those~~Innovation, ~~changes~~which ~~could~~appointed ~~have~~the aFederal ~~material~~Deposit ~~adverse~~Insurance ~~effect~~Corporation (“FDIC”) as receiver. Similarly, on ~~the~~March ~~business~~12, ~~investments~~2023, ~~and~~Signature ~~results~~Bank ofand ~~our~~Silvergate ~~operations~~Capital Corp. Inwere ~~addition,~~each aswept ~~failure~~into toreceivership. ~~comply~~Although ~~with~~a ~~applicable~~statement ~~laws~~by orthe ~~regulations~~Department of the Treasury, asthe ~~interpreted~~Federal Reserve and ~~applied,~~the ~~could~~FDIC ~~have~~indicated athat ~~material~~all ~~adverse~~depositors ~~effect~~of onSVB ~~our~~would ~~business~~have ~~and~~access ~~results~~to all of ~~operations.~~their Itmoney isafter ~~possible~~only ~~that~~one webusiness ~~will~~day ~~become~~of ~~subject~~closure, toincluding ~~different~~funds orheld ~~heightened~~in ~~rules~~uninsured ordeposit ~~requirements~~accounts, ~~promulgated~~borrowers byunder ~~the~~credit ~~SEC~~agreements, orletters ~~other~~of ~~regulators,~~credit and wecertain ~~may~~other ~~become~~financial ~~subject~~instruments towith ~~heightened~~SVB, Signature Bank or ~~increased~~any ~~scrutiny~~other financial institution that is placed into receivership by the ~~SEC.~~FDIC may be unable to access undrawn amounts thereunder.

OnWe ~~March~~had ~~30,~~immaterial ~~2022,~~exposure ~~the~~to ~~SEC~~one ~~proposed~~of ~~rules~~the ~~relating~~banks ~~to,~~swept ~~among~~into ~~other~~receivership ~~items,~~and ~~enhancing~~the ~~disclosures~~related infunds ~~business~~were ~~combination~~moved ~~transactions~~into ~~involving~~an ~~Special~~account ~~Purpose~~at ~~Acquisition~~a ~~Companies~~different ~~(“SPACs”)~~financial ~~and~~institution ~~private~~on ~~operating~~March ~~companies;~~9, ~~amending~~2023. ~~the~~We ~~financial~~also ~~statement~~continue ~~requirements applicable~~ to ~~transactions~~regularly ~~involving~~assess ~~shell~~our ~~companies;~~banking ~~enhancing~~relationships ~~disclosure~~and ~~with regards to~~ the ~~use~~location of ~~projections~~the inassets ~~SEC~~held ~~filings~~ in ~~connection~~the ~~with~~Trust ~~proposed~~Account ~~business~~as ~~combination~~we ~~transactions;~~believe ~~expanding~~necessary ~~the~~or ~~scope~~appropriate. ofHowever, ~~potential~~our ~~liability~~access ofto ~~certain~~funding ~~participants~~sources ~~in proposed business combination transactions;~~ and ~~the~~other ~~extent~~credit toarrangements ~~which~~could ~~SPACs~~be ~~could~~significantly ~~become~~impaired ~~subject~~by tofactors ~~regulation~~that ~~under~~affect the ~~Investment~~financial ~~Company~~services ~~Act~~industry ofor ~~1940~~economy in general. These ~~rules~~factors could include, ifamong ~~adopted~~others, ~~whether~~events insuch ~~the~~as ~~form~~liquidity ~~proposed~~constraints or infailures, ~~revised~~the ~~form,~~ability ~~may~~to ~~materially~~perform ~~adversely~~obligations ~~affect~~under ~~our~~various ~~ability~~types toof ~~negotiate~~financial, ~~and~~credit ~~complete~~or ~~our~~liquidity ~~initial~~agreements ~~Business~~or ~~Combination~~arrangements, ~~may~~disruptions ~~increase~~or ~~the~~instability ~~costs~~in ~~and~~the ~~time~~financial ~~related~~services ~~thereto~~industry.

Our search for a target, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the geopolitical uncertainty and macroeconomic environment resulting from the Russia-Ukraine conflict and subsequent sanctions against Russia, Belarus and related individuals and entities.

United States and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions that began in February 2022 from the conflict between Russia and Ukraine that have resulted in the deployment of military forces to eastern Europe, sanctions and other restrictive actions against Russia, Belarus and related individuals and entities. The conflict and the resulting measures that have been taken, and could be taken in the future, by the North Atlantic Treaty Organization, the United States, the United Kingdom, the European Union and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing military conflict in Ukraine is highly unpredictable, the conflict has and could continue to lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain disruptions. Additionally, Russian military actions and the resulting sanctions have and could continue to adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.

Any of the abovementioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the conflict and subsequent sanctions, could adversely affect our search for a business combination and any target business with which we ultimately consummate a business combination. The extent and duration of conflict, resulting sanctions and any related market disruptions are impossible to predict, but could be substantial, particularly if current or new sanctions continue for an extended period of time or if geopolitical tensions result in expanded military operations on a global scale. Any such disruptions may also have the effect of heightening many of the other risks described in the “Risk Factors” section of our Annual Report on Form 10-K, such as those related to the market for our securities or our ability to raise equity or debt financing in connection with any particular business combination.

‎

Table of Contents

We may be deemed a “foreign person” under the regulations relating to the Committee on Foreign Investment in the United States (“CFIUS”) and our failure to obtain any required approvals within the requisite time period may require us to liquidate.

CFIUS has authority to review direct or indirect investments by foreign persons in U.S. businesses. Under the CFIUS regulations, foreign investors may be required to make mandatory filings and pay filing fees related to such filings. CFIUS also has the authority to self-initiate national security reviews of foreign direct and indirect investments in U.S. businesses if the parties to that investment choose not to file voluntarily or at the request of CFIUS. In the case that CFIUS determines an investment to be a threat to national security, CFIUS has the power to block or impose mitigation measures on the investment. Whether CFIUS has jurisdiction to review an acquisition or investment transaction depends on, among other factors, the nature and structure of the transaction, including the level of beneficial ownership interest and the nature of any information or governance rights involved. For example, investments that result in “control” of a U.S. business by a foreign person always are subject to CFIUS jurisdiction. Certain investments that do not result in control of a U.S. business by a foreign person but afford certain foreign investors certain information or governance rights in a U.S. business involved in activities relating to “critical technologies,” “critical infrastructure” and/or “sensitive personal data” also are within the jurisdiction of CFIUS.

Our sponsor is a Cayman Islands limited liability company and is controlled by Kaszek Ventures Opportunity II, LP, a Cayman Islands exempted limited partnership (“Kaszek”), and MELI Capital Ventures LLC, a Cayman Islands limited liability company controlled by MercadoLibre, Inc., a Delaware corporation (“MELI”). Thus, our sponsor may be deemed to be a foreign person for CFIUS purposes. Our sponsor currently owns 12,739,286 Class L ordinary shares of the Company and 975,000 Class A ordinary shares of the Company. The co-managers of the Sponsor, Kaszek and MELI, by virtue of their shared control over our sponsor, may be deemed to beneficially own the Class A ordinary shares and Class L ordinary shares held by our sponsor. In addition, certain members of our Board are non-U.S. persons.

The Company may be deemed to be a “foreign person” under the regulations relating to CFIUS or may be subject to review by any other U.S. government entity. Further, although the Company intends to focus its search for an initial Business Combination on technology-enabled companies incorporated and operating in Latin America, targets with which the Company may pursue a Business Combination could include U.S. businesses or companies in Latin America that have subsidiaries or operations in the United States. As such, a Business Combination with a U.S. business or foreign business with U.S. subsidiaries or operations that we may wish to pursue may be subject to CFIUS review or other regulatory review, depending on the Company’s ultimate share ownership following the Business Combination and other factors.

If a particular proposed Business Combination falls within CFIUS’s jurisdiction, we may determine that we are required to make a mandatory filing or that we will submit to CFIUS review on a voluntary basis, or we may determine to proceed with the transaction without submitting to CFIUS and risk CFIUS intervention, before or after closing the transaction. CFIUS may decide to modify or delay our proposed Business Combination, impose conditions with respect to such Business Combination, request the President of the United States to order us to divest all or a portion of the U.S. target business that we acquire in our Business Combination without first obtaining CFIUS approval or prohibit the Business Combination entirely. Accordingly, the pool of potential targets with which the proposed Business Combination can occur may be limited. These risks may limit the attractiveness of, delay or prevent us from pursuing our initial Business Combination with certain target companies that we believe would otherwise be attractive to us and our shareholders.

Moreover, the process of government review or a decision to delay or prohibit the transaction, whether by CFIUS or otherwise, could be lengthy, and we have limited time to complete our Business Combination. If we are unable to consummate our Business Combination within the applicable time period required under the Company’s amended and restated memorandum and articles of association, we will be required to wind up, redeem and liquidate. In such event, our shareholders will miss the opportunity to benefit from an investment in a target company and the appreciation in value of such investment through a Business Combination.

A new 1% U.S. Federal excise tax could be imposed on us in connection with redemptions by us of our shares.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was signed into Federal law. The IRA provides for, among other things, a new U.S. Federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of the excise tax; however, no guidance has been issued to date.

Table of Contents

The IRA applies only to repurchases that occur after December 31, 2022. It is uncertain whether, and/or to what extent, the excise tax could apply to any redemptions of our public shares after December 31, 2022, including any redemptions in connection with initial Business Combination or a liquidation in the event we do not consummate an initial Business Combination by October 1, 2023. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination or otherwise may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax in connection with a Business Combination would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, (ii) the structure of the Business Combination, (iii) the nature and amount of any private investment in public equity or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by us, and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in our ability to complete a Business Combination.

We have identified a material weakness in our internal control over financial reporting. If we fail to maintain an effective system of internal controls over financial reporting in the future, any material weakness in the future could result in loss of investor confidence and adversely affect our business, including our ability to attract a prospective target, or stock price.

We reported in Part I, Item 4 of Amendment No. 1 to our Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 and Part II, Item 9A of Amendment No. 1 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, each filed with the SEC on November 21, 2022, that we identified a material weakness in connection with the misapplication of the calculation of the weighted-average number of ordinary shares outstanding for net income (loss) per ordinary share.

We have taken a number of measures to remediate the material weakness described therein; however, we can offer no assurance that these initiatives will ultimately have the intended effects; however, the elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. If we are unable to maintain effective internal control over financial reporting or disclosure controls and procedures, our ability to record, process and report financial information accurately, and to prepare financial statements within required time periods, could be adversely affected. Any material weaknesses identified in the future could adversely affect investor confidence in our financial statements and adversely affect our business, including our ability to attract a prospective target, or stock price.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On October 1, 2021, we consummated our ~~Initial~~IPO ~~Public Offering~~ of 28,750,000 shares, which includes the exercise in full of the underwriters’ option to purchase an additional 3,750,000 shares at $10.00 per share. Simultaneously with the consummation of the ~~Initial Public Offering~~IPO, the Company consummated the sale of 975,000 Private Placement Shares, at a price of $10.00 per share, generating aggregate gross proceeds to the Company of $9,750,000.

The securities sold in our ~~Initial~~IPO ~~Public Offering~~ were registered under the Securities Act on a registration statement on Form S-1 (No. 333-259473). The SEC declared the registration statement effective on September 28, 2021.

The Private Placement Shares were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The Private Placement Shares are identical to the Class A ordinary shares sold in the Initial Public Offering, except that (x) the Private Placement Shares will not be transferable, assignable or salable until 30 days after the completion of our initial Business Combination, subject to certain limited exceptions, (y) as long as the Private Placement Shares are held by our Sponsor or its permitted transferees, the Private Placement Shares will not be redeemable by us and (z) the Private Placement Shares are entitled to registration rights.

Of the gross proceeds received from the ~~Initial~~IPO ~~Public Offering~~ and the sale of Private Placement Shares, $287,500,000 was placed in the Trust Account.

Transaction costs of the ~~Initial~~IPO ~~Public Offering~~ amounted to $16,709,861 consisting of $5,750,000 of underwriting discounts and commissions, $10,062,500 of deferred underwriting discounts and commissions, and $897,361 of other offering costs. ~~During~~As ~~September~~of ~~2022~~December ~~two~~31, of2022, ~~the~~all four underwriters of the IPO waived their entitlement to ~~the~~this deferred underwriting discounts and commissions. ~~As a result, the underwriting discounts and commissions amounted to $7,546,875 as of September 30, 2022.~~

For a description of the use of the proceeds generated in our ~~Initial Public Offering~~IPO, see Part I, Item 2 of this Quarterly Report on Form 10-Q.

2523

Table of Contents

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

‎

2624

Table of Contents

ITEM 6. EXHIBITS.

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Exhibit No.		Description of Exhibit
31.1*	Certification of Principal ~~Executive~~Financial and Accounting Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal ~~Financial~~Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Principal ~~Executive~~Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	The cover page from the Company’s Form 10-Q for the quarterly period ended ~~September~~March 3031, ~~2022~~2023, formatted in Inline XBRL and contained in Exhibit 101



*	Filed or furnished herewith, as applicable.

‎

2725

Table of Contents

SIGNATURES

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MELI KASZEK PRIONEER CORP
Date: November 21, 2022	By:	/s/ Hernan Kazah
Date: May 10, 2023	By:	/s/ Hernan Kazah
	Name:	Hernan Kazah
	Title:	Co-Chief Executive Officer

Date: November 21, 2022	By:	/s/ Pedro Arnt
Date: May 10, 2023	By:	/s/ Pedro Arnt
	Name:	Pedro Arnt
	Title:	Co-Chief Executive Officer

2826

Filing Compare · MELI Kaszek Pioneer Corp